🇺🇸 FDA
Pipeline program

Melphalan flufenamide (Melflufen)

OP-106

Phase 2 small_molecule completed

Quick answer

Melphalan flufenamide (Melflufen) for Multiple Myeloma is a Phase 2 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Multiple Myeloma
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials